Strontium ranelate (Protelos) is a drug approved for the treatment of osteoporosis in Europe, but not in Canada. It is effective in reducing fractures . Recently the European Medicines Agency […]

Updates on Bone Health:Physical activity and exercise Updates on Bone Health:Physical activity and exercise A continuing education program for those treating and training people with osteoporosis. Your presenters are: Barb […]

New FLS sites in BC and PEI The ongoing collaboration between The Brookfield Chair in Fracture Prevention and Osteoporosis Canada has resulted in a new program BreakFree – resulting in […]

Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]

Latest News Clinical Practice Guideline – Top 2023 Article on CMAJ.ca January 29, 2024 On October 10, 2023 a new guideline on the management of osteoporosis and fracture prevention was […]

Latest News IAB Membership Cycle Applications Being Accepted January 12, 2024 Canadian Institutes of Health Research (CIHR) The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for […]

Vitamin D is a crucial nutrient for bone health. In this presentation Stephanie Atkinson, PhD discusses: Vitamin D –why do we need it? Does the new Canada’s Food Guide provide […]

GET SUPPORT Support Resources Osteoporosis Canada currently produces publications in various languages. LEARN MORE Let’s Talk The information line gives you access to trained and compassionate staff and volunteers who […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]